ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 73 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $1,248,000 | +21.3% | 269,000 | +59.2% | 0.00% | +50.0% |
Q3 2015 | $1,029,000 | +1154.9% | 169,000 | +823.3% | 0.00% | – |
Q1 2015 | $82,000 | +60.8% | 18,303 | -31.4% | 0.00% | – |
Q3 2014 | $51,000 | -87.9% | 26,700 | -78.6% | 0.00% | -100.0% |
Q2 2014 | $423,000 | +29.8% | 124,899 | +28.2% | 0.00% | 0.0% |
Q1 2014 | $326,000 | +59.0% | 97,400 | +46.0% | 0.00% | – |
Q4 2013 | $205,000 | +6.2% | 66,700 | +38.8% | 0.00% | – |
Q3 2013 | $193,000 | – | 48,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 2,535,564 | $7,835,000 | 4.00% |
ProQuest Associates IV LLC | 1,900,000 | $5,871,000 | 2.39% |
Abingworth LLP | 437,994 | $1,349,000 | 1.41% |
Hilltop Park Associates LLC | 75,000 | $232,000 | 0.97% |
Broadfin Capital, LLC | 1,154,674 | $3,568,000 | 0.35% |
Perceptive Advisors | 1,492,156 | $4,611,000 | 0.32% |
Rhenman & Partners Asset Management AB | 300,000 | $927,000 | 0.16% |
Rock Springs Capital Management LP | 450,000 | $1,391,000 | 0.10% |
WEXFORD CAPITAL LP | 145,622 | $450,000 | 0.08% |
BOOTHBAY FUND MANAGEMENT, LLC | 15,960 | $49,000 | 0.02% |